Sunshine Biopharma Inc.
SBFM· Nasdaq
SBFMSunshine Biopharma Inc.
Filed Aug 10, 2023 · 10-Q · 41 days after period end · 0001683168-23-005518
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $5.56M | $150.31K | $52.87K | $15.15K |
| Net Income | -$902.11K | -$538.87K | -$2.88M | -$907.44K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sunshine Biopharma Inc. · CIK 1402328 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 10, 2023 · 41 d after period end
